PCA Investment Advisory Services’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-100
Closed -$5.61K 170
2023
Q2
$5.61K Buy
+100
New +$5.61K ﹤0.01% 423